2025-01-16 09:55:53
Ascletis Announces Completion of 149 Patient Enrollment and Positive Interim Results of Phase IIb Chronic Hepatitis B Study in China for its Subcutaneously Administered PD-L1 Antibody ASC22 (Envafolimab)
Corporate/ 2023-07-23
Ascletis Announces Completion of 149 Pat...

HBsAg reduction was observed in the 1 mg/kg ASC22 once every two weeks plus nucleos(t)ide analogs group with greater HBsAg reduction observe...

India-based MedTel receives investment term sheet from Catalist-listed Metal Component Engineering (MCE, SGX:5DX)
Corporate/ 2023-07-23
India-based MedTel receives investment t...

SINGAPORE,July 28,2021--Catalist-listed Metal Component Engineering Limited ("MCE") is pleased to announce that it has,through its...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release